The company continues to acquire large customers and gain accolades for its quality and clinical MedTech solutions.
Greenlight Guru, the leading provider of cloud-based quality and clinical software for MedTech companies, announces today strong results in Q4 and for the full year of 2023 as the company continues to enhance its product offerings and expand its customer base, particularly with large, global MedTech companies. Greenlight Guru acquired more than 300 new customers in 2023 and saw high rates of expansion from existing customers as the company released new updates to its software.
As part of its commitment to continuous improvement and customer advocacy, Greenlight Guru made several enhancements to its MedTech Suite of purpose-built products in Q4. These include additional endpoints for its APIs, upgrades to its new Risk Management workspace, and the introduction of automation in the Training Management workspace to ease the manual burden on training managers.
“Customer satisfaction is at the heart of our philosophy here,” said Stanley Finkelshteyn, VP of Product at Greenlight Guru. “We’ve listened closely to what our customers are asking for, and we’re consistently delivering the enhancements and features that are going to make the biggest impact for their organizations. We’re extremely excited about our product roadmap for 2024.”
Greenlight Guru will be showcasing its new 2024 product releases and giving a preview of future enhancements at a webinar on Thursday, January 25th. You can register here.
Greenlight Guru’s commitment to its customers showed up in the G2 Winter Grid Report, where the company’s Quality Management software was once again ranked as the #1 solution in the Medical QMS category. The product was also awarded Best Results, Best Relationship, and Most Implementable. As one customer review states, “Greenlight Guru… has made document management, review and approval very efficient. The software is user friendly and most of our staff are able to use it intuitively. Greenlight Guru is very focused on making improvements and they have taken on much of our feedback and acted on it.”
Greenlight Guru Clinical (formerly SMART-TRIAL) also had a strong showing in the G2 Winter Grid Report, debuting as a Leader in the Electronic Data Capture (EDC) category and earning the “Users Love Us” badge. One customer described Greenlight Guru Clinical as, “A very smart and comprehensive tool, easy to implement and to be used for all stakeholders who are involved in the study – sponsor, CRA, physicians and coordinators. We use it frequently for multiple studies with a high satisfaction.”
In addition to the new product updates and accolades, in Q4 Greenlight Guru released a groundbreaking report on the use of AI in the MedTech industry—the AI in MedTech Trend Report 2023. The Report showed that while industry adoption of AI tools for MedTech companies is generally low, the interest in AI and its potential application for medical devices is very high. Greenlight Guru has integrated AI into its Risk Intelligence solution, providing AI-generated insights from industry databases so MedTech teams can proactively identify, document, and mitigate risk with more accuracy throughout the device lifecycle. Additionally, the company is currently beta testing an AI-powered chat solution called Digital Guru that offers on-demand insights specifically trained and tailored for MedTech companies.
“We ended 2023 on a high note,” said David DeRam, CEO of Greenlight Guru. “This was a tough year for a lot of SaaS companies, but Greenlight Guru continued to see positive growth trends, and we are in a position of strength to start 2024. We’ll use that momentum to continue making strategic investments in our solutions to support the innovative MedTech companies that are working to improve lives around the world.”